GlassScriptPhysician profile
Bridgette M Baker
NPI 1265693386
$427.28
in general payments reported to CMS, 2019-2025
15 companies · $226 in 2025
The $226 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.63 · 2024: $136 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $362.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $84.21 | 2019-2025 | |
| Astellas Pharma US INC | $78.54 | 2024-2025 | Veozah |
| Lilly USA, LLC | $36.11 | 2025 | Zepbound, Mounjaro |
| Dexcom, INC. | $36.08 | 2024 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $30.32 | 2024-2025 | Rybelsus, Ozempic |
| Recor Medical INC | $18.64 | 2024 | Paradise Renal Denervation System |
| E.R. Squibb & Sons, L.L.C. | $18.41 | 2024 | Eliquis |
| Exeltis, USA INC. | $17.80 | 2025 | Slynd |
| Phathom Pharmaceuticals, INC. | $17.22 | 2025 | Voquezna |
| Genentech USA, INC. | $17.03 | 2019 | |
| Corcept Therapeutics | $16.26 | 2025 | Korlym |
| Astrazeneca Pharmaceuticals LP | $16.26 | 2025 | Breztri |
| Amgen INC. | $15.56 | 2024 | Prolia, Evenity |
| Abbvie INC. | $13.71 | 2025 | |
| Sonex Health, INC. | $11.13 | 2025 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridgette Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.